Home/Filings/4/0001169245-21-000012
4//SEC Filing

Arnold Susan Elizabeth 4

Accession 0001169245-21-000012

CIK 0001169245other

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 4:50 PM ET

Size

5.6 KB

Accession

0001169245-21-000012

Insider Transaction Report

Form 4
Period: 2021-02-05
Arnold Susan Elizabeth
VP, Preclinical and Chem.
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-02-05+36,00036,000 total
    Exercise: $4.31Exp: 2031-02-05Common Stock (36,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option shall vest in equal monthly installments over 48 months from February 5, 2021, subject to the reporting person's continued service through each such date.

Issuer

PhaseBio Pharmaceuticals Inc

CIK 0001169245

Entity typeother

Related Parties

1
  • filerCIK 0001755746

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:50 PM ET
Size
5.6 KB